Synonyms: CL 227,193 | CL-227193 | PIPC | T-1220 | Tazocin® (piperacillin + tazobactam)
piperacillin is an approved drug (FDA (1981), UK (2011))
Compound class:
Synthetic organic
Comment: Piperacillin is a broad-spectrum semisynthetic, ampicillin-derived antibacterial.
|
|
No information available. |
Summary of Clinical Use ![]() |
Piperacillin (as the sodium salt) is used to treat moderate-to-severe infections due to susceptible organisms. In the UK, piperacillin is approved in a number of combination products with tazobactam, which are all administered intravenously (e.g. Tazocin). Tazocin is indicated for the treatment of severe pneumonia, complicated urinary tract infections, complicated intra-abdominal infections, complicated skin and soft tissue infections, or bacteraemia that arises from any of these infections. The UK National Institute for Health and Care Excellence (NICE) recommends piperacillin-tazobactam as initial empiric treatment for patients with suspected neutropenic sepsis [2]. |
External links ![]() |
For extended ADME data see the following: Electronic Medicines Compendium (eMC) Drugs.com |